Subsequent Events

3 Months Ended

Mar. 31, 2020

Subsequent Events [Abstract]

Subsequent Events

14. Subsequent Events

In April 2020, preclinical research activities contemplated under the original research plan, in connection with the Research Agreement, have been curtailed. The Company is currently in discussions with AstraZeneca regarding the future scope of translational and clinical activities to be performed under the research plan.  While we discuss with AstraZeneca the scope of future activities to be performed under the research plan we expect revenue recognized under the Research Agreement to decrease.